摘要:
A hand held electrically powered planer including a housing; an electric motor mounted within the housing; a work piece engaging shoe mounted on the underside of the housing having an aperture formed therethrough; and a cutting drum rotatably mounted within the housing, which is capable of being rotatably driven by the electric motor when the electric motor is activated. A part of the cutting drum protrudes through the aperture to engage a work piece. A cutting blade is mounted on the cutting drum. A rear handle is mounted on the housing and includes an elongate shaft attached at one end only to the rear of the housing and extends forward in a lengthwise direction over a portion of the housing toward the front end of the housing. A grip is mounted or formed on the elongate shaft and there is a front handle which is mounted on the free end of the shaft forward of the grip.
摘要:
A hand held electrically powered planer including a housing; an electric motor mounted within the housing; a work piece engaging shoe mounted on the underside of the housing having an aperture formed therethrough; and a cutting drum rotatably mounted within the housing, which is capable of being rotatably driven by the electric motor when the electric motor is activated. A part of the cutting drum protrudes through the aperture to engage a work piece. A cutting blade is mounted on the cutting drum. A rear handle is mounted on the housing and includes an elongate shaft attached at one end only to the rear of the housing and extends forward in a lengthwise direction over a portion of the housing toward the front end of the housing. A grip is mounted or formed on the elongate shaft and there is a front handle which is mounted on the free end of the shaft forward of the grip.
摘要:
The present invention is directed to compounds of Formula I: I (where variables A1, A2, B, J, K, m, n, R4, R5a, R5b and R5c are as defined herein) useful as antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as headache, migraine and cluster headache. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.
摘要翻译:本发明涉及式I的化合物:I(其中变量A 1,A 2,B,J,K,m,n,R 4 R 5c,R 5b和R 5c如本文所定义)可用作CGRP受体的拮抗剂并且可用于治疗 或预防CGRP所涉及的疾病,如头痛,偏头痛和丛集性头痛。 本发明还涉及包含这些化合物的药物组合物以及这些化合物和组合物在预防或治疗涉及CGRP的疾病中的用途。
摘要:
The present invention is directed to compounds that are antagonists of CGRP receptors and that are useful in the treatment or prevention of diseases in which the CGRP is involved, such as headache, migraine and cluster headache. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.
摘要:
This invention relates to certain novel piperazine compounds and derivatives thereof, their synthesis, and their use as oxytocin receptor antagonists. One application of these compounds is in the treatment of preterm labor in mammals, especially humans. The ability of the compounds to relax uterine contractions in mammals also makes them useful for treating dysmenorrhea and stopping labor prior to cesarean delivery.
摘要:
Compounds of formula I: wherein variables A1, A2, B, m, n, J, R4, G1, G2, G3 and Y are as described herein, which are antagonists of CGRP receptors and which are useful in the treatment or prevention of diseases in which the CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.
摘要:
A method of providing a uniform user experience is described. The method entails receiving general preference information, and mapping the general preference information to format-specific preference information. This format-specific preference information can then be applied when accessing content.
摘要:
Compounds of formula I: wherein variables A1, A2, B, m, n, J, R4, G1, G2, G3 and Y are as described herein, which are antagonists of CGRP receptors and which are useful in the treatment or prevention of diseases in which the CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.
摘要:
Compounds of formula I: wherein variables A1, A2, B, m, n, J, R4, G1, G2, G3 and Y are as described herein, which are antagonists of CGRP receptors and which are useful in the treatment or prevention of diseases in which the CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.
摘要:
The present invention is directed to compounds that are antagonists of CGRP receptors and that are useful in the treatment or prevention of diseases in which the CGRP is involved, such as headache, migraine and cluster headache. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.